Synta Pharmaceuticals. (NSDQ: SNTA) added Mar 28, 2011
Synta Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel pharmaceutical products for extending and enhancing the lives of patients with severe medical conditions, including cancer and chronic inflammatory disease. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All clinical candidates were invented internally by Synta scientists using our compound library and discovery capabilities.
Recent News: Synta to Host Investigator Panel Session on New Clinical Opportunities for Hsp90 Inhibition in Oncology
Synta Announces Clinical Program Updates and 2010 Financial Results
George Farmer, Ph.D .....Canaccord/Genuity….Mar 25, 2011
Maintained BUY
Target $8.00US
SNTA Price day before:$5.05Finish day posting$5.16Current $5.16
----Feb 28, 2011------
Upgraded to BUY from HOLD
Target raised to $8.00 from $4.50US
SNTA Price day before:$5.29Finish day posting$5.59Current $5.16
******************
Jim Birchenough .....Barclays Capital….Mar 14, 2011
Maintained EQUALWEIGHT
Target raised to $4.00 from $2.00US
SNTA Price day before:$4.68Finish day posting$4.50Current $5.16
******************
George Zavoico .....MLV LLC….Nov 09, 2010
New BUY
Target $8.50US
SNTA Price day before:$3.53Finish day posting$3.47Current $5.16
******************
Shiv Kapoor .....Morgan Joseph….Feb 28, 2011
Maintained BUY
Target raised to $8.50 from $6.00US
SNTA Price day before:$5.19Finish day posting$5.05Current $5.16
-----Aug 26, 2010------
New BUY
Target $6.00US (Target Hit Dec 15, 2010)
SNTA Price day before:$2.82Finish day posting$2.86Current $5.16
******************
Andrew Vaino .....Roth Capital Partners….May 10, 2010
Upgraded to BUY from HOLD
Target $4.00US (Target Hit June 15, 2010)
SNTA Price day before:$3.11Finish day posting$3.33Current $5.16
******************
Jason Kantor .....RBC Capital Markets….Feb 19, 2010
New SECTOR PERFORM
Target $5.00US (Target Hit Dec 06, 2010)
SNTA Price day before:$4.20Finish day posting$4.27Current $5.16